Mahdi Basha, DO
Ophthalmology · Fraser, MINPI 1396900379
Payments from drug & device makers
Across 780 payments — averaging $2851.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.7M
- Glaukos Corporation$207K
- Alcon Research LLC$179K
- Oyster Point Pharma, Inc.$84K
- Ivantis, Inc$26K
- Alcon$4K
- plus $4K from 22 others
Across 14 payments — averaging $193.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 307 | $1,720,690 |
| Glaukos Corporation | 128 | $206,738 |
| Alcon Research LLC | 206 | $179,491 |
| Oyster Point Pharma, Inc. | 16 | $83,751 |
| Ivantis, Inc | 9 | $26,337 |
| Alcon | 58 | $3,723 |
| Ocular Therapeutix, Inc. | 1 | $2,675 |
| Novartis | 10 | $161 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $121 |
| Aerie Pharmaceuticals, Inc. | 4 | $112 |
| Rxsight Inc | 5 | $100 |
| Optos, Inc. | 1 | $92 |
| Amgen(2 entities) | 5 | $79 |
| Bausch & Lomb Americas Inc. | 4 | $75 |
| Thea Pharma Inc. | 3 | $58 |
| Tarsus Pharmaceuticals, Inc. | 2 | $47 |
| Akorn Operating Company LLC | 2 | $36 |
| Lombart Brothers, Inc. | 1 | $31 |
| Eyepoint US, Inc. | 2 | $28 |
| NEW World Medical,inc. | 1 | $25 |
| Eyevance Pharmaceuticals LLC | 2 | $24 |
| Carl Zeiss Meditec USA, Inc. | 1 | $19 |
| Akorn, Inc. | 1 | $18 |
| Kala Pharmaceuticals, Inc. | 1 | $18 |
| Spark Therapeutics, Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
How this compares
$2,224,507 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Fraser
- Thomas WubbenAnn Arbor$1.2M
- Manjool ShahAnn Arbor$745K
- Scott WesthouseGrand Rapids$525K
- Gregory KatzYpsilanti$495K
- Cagri BesirliAnn Arbor$441K
- David BrownSaint Joseph$432K
- Vinay AakaluAnn Arbor$429K
- Timothy PageBirmingham$324K
- David CookeSaint Joseph$276K
- Leslie GrosingerBloomfield Hills$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.